Literature DB >> 15084818

Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage.

Toshihiko Nakaizumi1, Kohei Kawamoto, Ryosei Minoda, Yehoash Raphael.   

Abstract

Hair cell loss, the most common cause of deafness, is often associated with auditory nerve degeneration. Our goal was to determine the influence of combined ciliary-derived neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF) gene therapy on the survival of spiral ganglion neurons (SGNs) after elimination of inner hair cells in the mature guinea pig ear. Seven days after bilateral deafening, a 5-microl suspension of CNTF and/or BDNF adenovirus vectors was injected into the left scala tympani through the round window. Animals were sacrificed 28 days after deafening, and their inner ears were prepared for SGN counts. The SGN counts revealed that BDNF alone and the combined CNTF and BDNF treatment significantly enhanced SGN survival. CNTF did not significantly enhance the protective effect of BDNF. These data present possible strategies for enhancing SGN survival in cochlear implant procedures. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084818     DOI: 10.1159/000077264

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  42 in total

Review 1.  Future approaches for inner ear protection and repair.

Authors:  Seiji B Shibata; Yehoash Raphael
Journal:  J Commun Disord       Date:  2010-04-08       Impact factor: 2.288

2.  AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.

Authors:  Patricia A Leake; Stephen J Rebscher; Chantale Dore'; Omar Akil
Journal:  J Assoc Res Otolaryngol       Date:  2019-06-20

Review 3.  Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system.

Authors:  Lisa N Pettingill; Rachael T Richardson; Andrew K Wise; Stephen J O'Leary; Robert K Shepherd
Journal:  IEEE Trans Biomed Eng       Date:  2007-06       Impact factor: 4.538

Review 4.  [Protection and regeneration of sensory epithelia of the inner ear].

Authors:  S Pfannenstiel; M Praetorius
Journal:  HNO       Date:  2008-01       Impact factor: 1.284

5.  Dual Release Carriers for Cochlear Delivery.

Authors:  Sahar Rahmani; Astin M Ross; Tae-Hong Park; Hakan Durmaz; Acacia F Dishman; Diane M Prieskorn; Nathan Jones; Richard A Altschuler; Joerg Lahann
Journal:  Adv Healthc Mater       Date:  2015-07-14       Impact factor: 9.933

Review 6.  Current status and prospects of gene therapy for the inner ear.

Authors:  Hong Sun; Aji Huang; Shousong Cao
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

7.  Postnatal expression of neurotrophic factors accessible to spiral ganglion neurons in the auditory system of adult hearing and deafened rats.

Authors:  Erin M Bailey; Steven H Green
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

Review 8.  Gene therapy in the inner ear using adenovirus vectors.

Authors:  Jacob Husseman; Yehoash Raphael
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

9.  Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons.

Authors:  Jennifer A Chikar; Deborah J Colesa; Donald L Swiderski; Adriana Di Polo; Yehoash Raphael; Bryan E Pfingst
Journal:  Hear Res       Date:  2008-08-19       Impact factor: 3.208

Review 10.  The use of neurotrophin therapy in the inner ear to augment cochlear implantation outcomes.

Authors:  Cameron L Budenz; Bryan E Pfingst; Yehoash Raphael
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.